Detection of human cytomegalovirus and epstein-barr virus in coronary atherosclerotic tissue

Ana Vitória Imbronito, Silvia Linardi Marcelino, Sabrina Rosa Grande, Fabio Daumas Nunes, Giuseppe Alexandre Romito, Ana Vitória Imbronito, Silvia Linardi Marcelino, Sabrina Rosa Grande, Fabio Daumas Nunes, Giuseppe Alexandre Romito

Abstract

Previous studies indicated that patients with atherosclerosis are predominantly infected by human cytomegalovirus (HCMV), but rarely infected by type 1 Epstein-Barr virus (EBV-1). In this study, atheromas of 30 patients who underwent aortocoronary bypass surgery with coronary endartherectomy were tested for the presence of these two viruses. HCMV occurred in 93.3% of the samples and EBV-1 was present in 50% of them. Concurrent presence of both pathogens was detected in 43.3% of the samples.

Keywords: Epstein-Barr virus; atherosclerosis; cytomegalovirus.

References

    1. Almeida, G.D.; Porada, C.D.; St Jeor, S.; Ascencao, J.L. (1994). Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 83(2), 370-376.
    1. Blankenberg, S.; Rupprecht, H.J.; Bickel, C.; Espinola-Klein C.; Rippin G.; Hafner G. et al (2001). Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease. Circulation 103(24), 2915-2921.
    1. Darlington, J.; Super, M.; Patel, K.; Grundy, J.E.; Griffiths, P.D.; Emery, V.C. (1991). Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J. Gen. Virol 72, 1985-1989.
    1. De Boer, O.J.; Becker, A.E.; van der Wal, A.C. (2003). T-lymphocytes in atherogenesis-functional aspects and antigenic repertoire. Cardiovasc. Res. 60 (1), 78-86.
    1. Epstein, S.E.; Zhou, Y.F.; Zhu. J. (1999). Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 100 (4), e20–28.
    1. Epstein, S.E.; Zhu, J.; Burnett, M.S.; Zhou, Y.F.; Vercellotti, G.; Hajjar, D. (2000). Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler. Thromb. Vasc. Biol. 20 (6), 1417-20.
    1. Espy, M.J.; Smith, T.F. (1995) Comparison of SHARP signal system and Southern blot hybridization analysis for detection of cytomegalovirus in clinical specimens by PCR. J. Clin. Microbiol. 33, 3028-3030.
    1. Etingin, O.R.; Silverstein, R.L.; Friedman, H.M.; Hajjar, D.P. (1990). Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell. 18; 61 (4), 657-662.
    1. Fong, I.W. (2000). Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. Canad. Med. Assoc. J. 163 (1), 49-56.
    1. Fong, I.W. (2002). Infections and their role in atherosclerotic vascular disease. JADA. 133 (Suppl), 7S-13S.
    1. Grahame-Clarke, C.; Chan, N.N.; Andrew, D.; Ridgway, G.L.; Betteridge, D.J.; Emery, V., Colhoun H.M.; Vallance, P. (2003). Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation. 12, 108 (6), 678-683.
    1. Gratton, M.T. (1991). Accelerated graft atherosclerosis following cardiac transplantation: clinical perpectives. Clin. Cardiol 141 (Suppl 2), 16-20.
    1. Grundy, J.E.; Downes, K.L. (1993). Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology. 78 (3), 405-412.
    1. Hajjar, D.P.; Fabricant, C.G; Minick, C.R; Fabricant, J. (1986). Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am. J. Pathol. 1986; 122 (1), 62-70.
    1. Hendrix, M.G.; Salimans, M.M.; van Boven, C.P.; Bruggeman, C.A. (1990). High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136 (1), 23-8.
    1. Iwamoto, G.K.; Konicek, S.A. (1997). Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression. J. Invest. Med. 45 (4), 175–82.
    1. Macsween, K.F.; Crawford, D.H. (2003). Epstein-Barr virus- recent advances. Lancet Infect. Dis 3 (3), 131-140.
    1. Shi, Y.; Tokunaga, O. (2002). Herpresvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol. Int. 52 (1), 31-39.
    1. Musiani, M.; Zerbini, M.L.; Muscari, A.; Puddu, G.M.; Gentilomi, G.; Gibellini, D. et al (1990). Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis. Microbiologica. 13(1). 35-41.
    1. Rupprecht, H.J.; Bickel, C.; Rippin, G.; Hafner, G.; Prellwitz, W.; Schlumberger, W.; Meyer, J. (2001). Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 104(1), 25-31.
    1. Speir, F.; Yu, Z.X.; Ferrans, V.J. (1998). Infectious agents in coronary artery disease: viral infection, aspirin and gene expression in human coronary smooth cells. Rev. Port. Cardiol. 17 (Suppl 2), II33-39.
    1. Zhou, Y.F.; Leon, M.B.; Waclawiw, M.A.; Popma, J.J.; Yu, Z.X.; Finkel, T. Epstein, S.E. (1996). Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 29 (335), 624-630.
    1. Zhu, J.; Quyyumi, A.A.; Norman, J.E.; Csako, G.; Waclawiw, M.A.; Shearer, G.M.; Epstein, S.E. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. (2000). Am J Cardiol 85 (2), 140 –146.
    1. Zhu, J.; Nieto, F.J.; Horne, B.D.; Anderson, J.L.; Muhlestein, J.B.; Epstein, S.E. (2001). Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103 (1), 45–51.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi